Three items of pandemic news you may have missed recently: Post-vaccination breakthrough infections are less than 0.008%; researchers estimate how much virus an infection produces; and an advisory committee punts on J&J. Plus news briefs and a frippery. Advisory committee … Continue reading →
Three items of pandemic news you may have missed recently: A study on transmission from the vaccinated; the South African variant can evade Pfizer; and the US government suggests pausing J&J vaccination. Plus news briefs and a frippery. FDA and … Continue reading →
Three items of pandemic news you may have missed recently: A tapeworm remedy to fight Covid; you can stop sanitizing now; and a new concern about blood clots with the Johnson & Johnson vaccine. Plus news briefs and a frippery. … Continue reading →
Our intrepid time traveler, Julie Nolke, has released a fifth installment in her series. In this one a contemporary Julie, from April 2021, goes back for a wistful visit to the Julie of January 2020 — who was still blissfully … Continue reading →
Three items of pandemic news you may have missed recently: Canada is struggling; J&J is ordered to take over Emergent’s factory; and the mRNA vaccines appear safe and effective in pregnant women. Plus news briefs and a frippery. mRNA shots … Continue reading →
Three items of pandemic news you may have missed recently: Moderna can pack more doses per vial; Emergent’s big mistake; and news on vaccines for kids as young as 12. Plus news briefs and a pair of fripperies. Pfizer is … Continue reading →
Herewith three items of pandemic news you may have missed recently: Two more Russian vaccines; a primer on T-cell immunity; and fabulous results from a real-world study of vaccine effectiveness. Plus news briefs and two fripperies. 90% effective in the … Continue reading →
Herewith three items of pandemic news you may have missed recently: The latest installment in the ongoing AstraZeneca saga; how the immunosuppressed respond to mRNA vaccination; and Minnesota’s opening up of eligibility for shots. Plus news briefs and a frippery. … Continue reading →
Herewith three items of pandemic news you may have missed: Vitamin D levels vs. infection probability in Black people; variant viruses infecting animals; and the roller coaster that is AstraZeneca’s Phase III results announcement. Plus news briefs and a frippery. … Continue reading →
Herewith three items of pandemic news you may have missed recently: Reinfection is more likely after age 65; the EU gives AstraZeneca’s vaccine a less than resounding go-ahead; and long Covid in children. Plus news briefs and a frippery. Long … Continue reading →
Three items of pandemic news you may have missed recently: Kids and Covid-19; enhanced lethality of the B.1.1.7 variant; and more on the pause in AstraZeneca shots as Europe investigates a rare condition. Plus news briefs and a frippery. AstraZeneca … Continue reading →
Herewith three items of pandemic news you may have missed recently: Evidence that post-infection people could need only one shot; asymptomatics and long Covid; and AstraZeneca on pause across Europe over safety concerns. Plus news briefs and a frippery. AstraZeneca … Continue reading →
Herewith three items of pandemic news you may have missed recently: One instance in Oregon of a scary variant; quantifying the variants’ immune escape; and the new CDC guidelines. Plus news briefs and a frippery. A year Before we dive … Continue reading →
Herewith a couple of items of pandemic news you may have missed: Who is helping whom with manufacturing? And the impact of US export bans in support of Pfizer on vaccine production elsewhere. Plus news briefs and a frippery. US … Continue reading →
Herewith three items of pandemic news you may have missed recently: Youyang Gu’s model of the path to herd immunity; hesitancy from several directions about Johnson & Johnson’s vaccine; and the latest on pandemic passports. Plus news briefs and a … Continue reading →
